NO20003108L - Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger - Google Patents

Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger

Info

Publication number
NO20003108L
NO20003108L NO20003108A NO20003108A NO20003108L NO 20003108 L NO20003108 L NO 20003108L NO 20003108 A NO20003108 A NO 20003108A NO 20003108 A NO20003108 A NO 20003108A NO 20003108 L NO20003108 L NO 20003108L
Authority
NO
Norway
Prior art keywords
melatonin
pharmaceutical compositions
preparation
energetic
ligands
Prior art date
Application number
NO20003108A
Other languages
English (en)
Other versions
NO20003108D0 (no
Inventor
Sonia Pellissier
Anne Merle
Philippe Delagrange
Caroline Bennejean
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20003108D0 publication Critical patent/NO20003108D0/no
Publication of NO20003108L publication Critical patent/NO20003108L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anvendelse av melatonin og melatoninergiske Ugander for å oppnå farmasøytiske sammensetninger for forebyggingen ¿ og/eller behandlingen av patologier i det gastrointestinale system.
NO20003108A 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger NO20003108L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908019A FR2795323B1 (fr) 1999-06-23 1999-06-23 Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal

Publications (2)

Publication Number Publication Date
NO20003108D0 NO20003108D0 (no) 2000-06-16
NO20003108L true NO20003108L (no) 2000-12-27

Family

ID=9547206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003108A NO20003108L (no) 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger

Country Status (15)

Country Link
EP (1) EP1064941A1 (no)
JP (1) JP2001026539A (no)
KR (1) KR20010039680A (no)
CN (1) CN1283455A (no)
AU (1) AU4264800A (no)
BR (1) BR0002772A (no)
CA (1) CA2312432A1 (no)
EA (1) EA002823B1 (no)
FR (1) FR2795323B1 (no)
HU (1) HUP0002377A3 (no)
MX (1) MXPA00006145A (no)
NO (1) NO20003108L (no)
NZ (1) NZ505361A (no)
PL (1) PL340954A1 (no)
ZA (1) ZA200003165B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
WO2005039546A2 (en) 2003-10-03 2005-05-06 Veijlen N.V. Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
DK1667678T3 (da) 2003-10-03 2009-08-24 Veijlen N V Dyrefodersammensætning
TW200803837A (en) * 2006-03-20 2008-01-16 Takeda Pharmaceutical Prophylactic or therapeutic agent for irritable bowel syndrome
ES2384798B1 (es) * 2011-10-19 2013-06-04 Universidad De Granada Uso de melatonina para el tratamiento y/o prevención de la mucositis.
RU2693044C1 (ru) * 2018-05-28 2019-07-01 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеч Способ профилактики нпвп-гастропатии
WO2022157564A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A pharmaceutical composition comprising famotidine, lidocaine and melatonin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729147A1 (fr) * 1995-01-11 1996-07-12 Adir Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20003108D0 (no) 2000-06-16
HUP0002377A2 (hu) 2002-05-29
FR2795323B1 (fr) 2001-11-16
EA200000568A2 (ru) 2000-12-25
CA2312432A1 (fr) 2000-12-23
JP2001026539A (ja) 2001-01-30
PL340954A1 (en) 2001-01-02
EA002823B1 (ru) 2002-10-31
FR2795323A1 (fr) 2000-12-29
ZA200003165B (en) 2001-01-25
KR20010039680A (ko) 2001-05-15
EA200000568A3 (ru) 2001-02-26
BR0002772A (pt) 2001-01-30
CN1283455A (zh) 2001-02-14
HUP0002377A3 (en) 2002-08-28
MXPA00006145A (es) 2002-10-17
NZ505361A (en) 2002-02-01
AU4264800A (en) 2001-01-04
EP1064941A1 (fr) 2001-01-03

Similar Documents

Publication Publication Date Title
NO20015782D0 (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
ATE429210T1 (de) Orale flüssige zusammensetzungen
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
DE69806801T2 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
PT705100E (pt) Guanidinas substituidas terapeuticas
ZA908777B (en) Oral composition for the treatment of inflammatory bowel diseases
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
CA2408537A1 (en) Treating irritable bowel syndrome or disease
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
NO20003108L (no) Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE60026046D1 (de) 5-hydroxysapogenin derivate mit aktivität gegen demenz
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NO993784D0 (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
DK1294732T3 (da) Ruthenium (II)-forbindelser til anvendelse i cancerterapi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application